Literature DB >> 9756418

Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K.

H Habelhah1, F Okada, K Nakai, S K Choi, J Hamada, M Kobayashi, M Hosokawa.   

Abstract

Previously we reported the malignant progression of QR-32, a regressor-type tumor clone, following co-implantation with foreign bodies (gelatin sponge or plastic plate) in normal syngeneic C57BL/6 mice. We also reported that the progression of QR-32 cells by a gelatin sponge was significantly inhibited in the mice administered polysaccharide K (PSK) and that PSK induced an increase of radical scavengers, especially manganese superoxide dismutase (Mn-SOD), locally at the site of tumor tissues. In this study, to reveal the possible mechanism by which PSK induced Mn-SOD in the tumor tissues, we examined the mRNA expression and protein levels of inflammatory cytokines in the tissues. We found that mRNAs of tumor necrosis factor alpha (TNFalpha) and interleukin-1alpha (IL-1alpha) were considerably expressed in both PSK-treated and phosphate-buffered-saline-treated tumors, and that the mRNA expression and protein level of interferon gamma (IFNgamma) increased in the tumor tissues treated with PSK. In vitro treatment of QR-32 cells with IFNgamma did not significantly increase the production of Mn-SOD; however, the combination of IFNgamma with TNFalpha increased the Mn-SOD production more effectively than did any of the cytokines used singly. Furthermore, we observed the down-regulation of the mRNA expression and protein level of transforming growth factor beta (TGFbeta) in the tumor tissues treated with PSK, and that in vitro treatment of QR-32 cells with TGFbeta decreased the production of Mn-SOD. These results suggest that PSK suppresses the progression of QR-32 cells by increasing Mn-SOD via the modulation of inflammatory cytokines; that is, by decreasing TGF-beta and increasing IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756418     DOI: 10.1007/s002620050495

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  7 in total

1.  Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.

Authors:  H Zhang; T Morisaki; H Matsunaga; N Sato; A Uchiyama; K Hashizume; F Nagumo; J Tadano; M Katano
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.

Authors:  Kimiyasu Egami; Toyoaki Murohara; Toshifumi Shimada; Ken-Ichiro Sasaki; Satoshi Shintani; Takeshi Sugaya; Masahiro Ishii; Teiji Akagi; Hisao Ikeda; Toyojiro Matsuishi; Tsutomu Imaizumi
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 3.  Trametes versicolor mushroom immune therapy in breast cancer.

Authors:  Leanna J Standish; Cynthia A Wenner; Erin S Sweet; Carly Bridge; Ana Nelson; Mark Martzen; Jeffrey Novack; Carolyn Torkelson
Journal:  J Soc Integr Oncol       Date:  2008

4.  Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression.

Authors:  Hiroshi Tazawa; Futoshi Okada; Tokushige Kobayashi; Mitsuhiro Tada; Yukiko Mori; Yoshie Une; Fujiro Sendo; Masanobu Kobayashi; Masuo Hosokawa
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo.

Authors:  Norifumi Tsutsumi; Shunji Kohnoe; Hideto Sonoda; Atsushi Guntani; Tatsuya Rikimaru; Ken-Ichi Taguchi; Morimasa Tomikawa; Yoshihiro Kakeji; Hideaki Nakashima; Yoshihiko Maehara
Journal:  Oncol Lett       Date:  2011-07-04       Impact factor: 2.967

6.  Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase.

Authors:  F Okada; H Shionoya; M Kobayashi; T Kobayashi; H Tazawa; K Onuma; Y Iuchi; N Matsubara; T Ijichi; B Dugas; M Hosokawa
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

Review 7.  Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.

Authors:  Yusuke Kanda; Mitsuhiko Osaki; Futoshi Okada
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.